FDA Details Initial Thoughts on 3D-Printed Medical Devices

The GMP Letter
A A
The FDA finalized a more detailed “leapfrog guidance” on additive manufactured, or 3D-printed, medical technologies, outlining its latest thinking on technical considerations.

To View This Article:

Login

Subscribe To The GMP Letter